Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Abbas Abbas
Phase II Randomized Study of Two Regimens of Sequentially Administered Mitomycin C and Irinotecan in Patients With Unresectable Esophageal and Gastroesophageal Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
Phase II Study of the Triple Combination Chemotherapy of SOXIRI (S‐1/Oxaliplatin/Irinotecan) in Patients With Unresectable Pancreatic Ductal Adenocarcinoma
Oncologist
Cancer Research
Medicine
Oncology
Phase I and Pharmacokinetic Study of Mitomycin C and Celecoxib as Potential Modulators of Tumor Resistance to Irinotecan in Patients With Solid Malignancies
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Phase II Study of Bevacizumab and Preoperative Chemoradiation for Esophageal Adenocarcinoma
Journal of Gastrointestinal Oncology
Oncology
Gastroenterology
A Multicenter Phase 2 Study of AMG 337 in Patients With MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
A Multi-Center Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Cetuximab Plus Cisplatin, Irinotecan, and Thoracic Radiotherapy as Definitive Treatment for Locally Advanced, Unresectable Esophageal Cancer: A Phase-Ii Study of the SWOG (S0414)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Randomized Phase II Study of Cetuximab and Bevacizumab in Combination With Two Regimens of Paclitaxel and Carboplatin in Chemonaive Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
SWOG 0514: A Phase II Study of Sorafenib in Patients With Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma
Investigational New Drugs
Oncology
Pharmacology
Phase I Study of Celecoxib With Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients With Unresectable Locally Advanced Non-Small Cell Lung Cancer
Frontiers in Oncology
Cancer Research
Oncology
